NORSPAN Transdermal Patches Phase III Study In Non-Cancer Pain

Disease (or Disorder); Intervertebral Disc, With Myelopathy (Manifestation) Clinical Trial

Official title: NORSPAN Transdermal Patches Phase III Study In Non-Cancer Pain

Status Completed

Clinical Trial Summary

This is a multiple-dose, double-blind, double-dummy, active-control, parallel-group, multi-center, safety and efficacy study.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Disease
• Disease (or Disorder); Intervertebral Disc, With Myelopathy (Manifestation)
• Intervertebral Disc Degeneration
• Intervertebral Disc Displacement

• NCT number: NCT01476774
• Study type: Interventional
• Source: Mundipharma (China) Pharmaceutical Co. Ltd
• Status: Completed
• Phase: Phase 3
• Start date: August 2009